ArticleAnalytical chemistry2024
Electrochemical Immunoassay Platform for Human Monkeypox Virus Detection.
Article in Analytical chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Early Detection of Multiple Sclerosis Using Spectroscopic Epstein-Barr Virus Biosensors Based on Infection Mechanism Mimicry.Analytical chemistry · 2025Article
- Development of Epstein Barr virus biosensor by mimicking its infection mechanism for early detection of multiple sclerosis.Scientific reports · 2025Article
- Nanoparticles-based electrochemical sensing platform for high-through immunoassay with redox-activity CaCOMikrochimica acta · 2025Article
- Preparation and application evaluation of monoclonal antibodies against Monkeypox virus A29 protein.Frontiers in microbiology · 2025Article
- Biosensing technology for detection and assessment of pathogenic microorganisms.Future microbiology · 2025Review
- Advances and challenges of mpox detection technology.Biosafety and health · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we reported a selective impedimetric biosensor for the detection of A29 which is the target protein of the monkeypox virus (MPXV). The working principle of the biosensor relies on the interaction mechanism between A29, which is an internal membrane protein of MPXV, and the heparan sulfate receptor. For this purpose, after immobilizing heparan sulfate onto the gold screen-printed electrode surface, its interaction with A29 protein was monitored using electrochemical impedance spectroscopy. After the optimization of experimental parameters, the analytical characteristics of the developed MPVX immunosensor were examined. The developed immunosensor exhibited a linear detection range between 2.0 and 50 ng mL
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.